Drug-eluting stent restenosis: a need for new technology?

  • John Douglas
  • Published 2012 in JACC. Cardiovascular interventions

Abstract

In this 35th year of percutaneous coronary intervention, restenosis after stent implantation remains a significant limitation, resulting in increased costs and morbidity, reduced quality of life, and in some patients, a need for surgical coronary revascularization. Drug-eluting stents (DES) proved superior to bare-metal stents (BMS) in preventing restenosis… (More)
DOI: 10.1016/j.jcin.2012.03.019

Topics

Cite this paper

@article{Douglas2012DrugelutingSR, title={Drug-eluting stent restenosis: a need for new technology?}, author={John Douglas}, journal={JACC. Cardiovascular interventions}, year={2012}, volume={5 7}, pages={738-40} }